PERTH-based biotechnology company EQiTX Ltd has appointed former Pfizer senior executive Kevin Fahey to its board of directors.
In addition to working for Pfizer, the world’s largest pharmaceutical company, Dr Fahey held executive research management positions in the US for more than 10 years.
Prior to joining Pfizer, he worked for SmithKline Beecham Animal Health in Nebraska, where he was vice president and director, biologicals research and development.
Brian Nathanson has also secured a place on the EQiTX board of directors.
He has been acting as the company’s corporate consultant since December 2001.
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.